Search

Search Constraints

You searched for: Author/Creator Kumar, Alan Prem

Search Results

11. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy. (November 2022)

13. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance. (3rd April 2022)

14. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. (1st October 2013)

15. Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. (December 2022)

16. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. (1st September 2018)

17. Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) – experimental validation in human breast and colon cancer. Issue 11 (1st November 2016)

18. Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery. (November 2021)

19. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression. (15th November 2021)

20. In response to "Comment on "Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?" Cancer Lett. 2021 May 2; 509 (2021) 63–80". (28th September 2021)